Why I bought more of this ASX 200 stock

I'm optimistic about the future of this business.

| More on:
Man smiling at a laptop because of a rising share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

My latest investment was the S&P/ASX 200 Index (ASX: XJO) stock Washington H. Soul Pattinson and Co. Ltd (ASX: SOL), which I decided to purchase last week.

It's already one of the biggest positions in my portfolio, and I keep going back for more.

The investment conglomerate has been growing shareholder wealth for 120 years, and I think it's going to be a useful core position in my portfolio for the rest of my life.

I regularly write about how much I like this business, with its high level of diversification in the portfolio. It's invested in areas like building products, industrial property, telecommunications, resources, swimming schools, electrification, agriculture, credit/bonds and financial services.

Why I continue buying this ASX 200 stock

The track record of this company is impressive – in the 20 years to 31 July 2024, it has returned an average of 11.7% per annum, beating the market by an average of 3% per annum during that period.

As a bonus, it continues growing its dividend, which I find appealing. The payout has risen every year since 2000. Investors can choose to reinvest their dividends or receive them as cash.

Remember, past performance is certainly not a guarantee of future performance.

I believe Soul Patts' current portfolio is well-suited to keep performing in the shorter term, whether the Australian economy enters a recession or starts recovering. Its defensive, cash-flow-producing assets are an excellent attribute of the company

However, the world is always changing. Businesses need to be able to adapt to continue to succeed. No one can truly know how the artificial intelligence (AI) theme will play out or what the next meaningful geopolitical event or any other 'macro' event will be.

I think the best attribute of this ASX 200 stock is that it has a very flexible investment mandate. It can invest in almost anything, any market capitalisation, listed or private equity, different asset classes (such as bonds), and even different countries.

Soul Patts started as a pharmacy business in the early 1900s, and it only recently divested its exposure to pharmacies when Australian Pharmaceutical Industries was acquired by Wesfarmers Ltd (ASX: WES). Soul Patts is an entirely different business.

The company's portfolio could look very different in 20 or 30 years, but Soul Patts has shown it's willing to adapt its portfolio to ensure its long-term success. Recent investments include electrification, agriculture and swimming schools. It operates like a family office, with a strategy that could ensure multi-generational success.

It may not perform like a high-flying ASX growth share, but its active investment choices and flexibility could help it remain a good ASX 200 stock for many years to come.

Motley Fool contributor Tristan Harrison has positions in Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Washington H. Soul Pattinson and Company Limited and Wesfarmers. The Motley Fool Australia has positions in and has recommended Washington H. Soul Pattinson and Company Limited and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

1 ASX dividend stock down 17% I'd buy right now

I’d happily do some pre-Christmas portfolio shopping with this ASX dividend stock.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Opinions

2 ASX shares to buy and hold for the next decade

I’m backing these ASX shares as long-term buys.

Read more »

a hand reaches out with australian banknotes of various denominations fanned out.
Opinions

2 incredible ASX shares I'd buy with $2,000 right now

These investments have global growth potential…

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Opinions

I'd buy this ASX dividend stock in any market

I’m planning to buy plenty more of this ASX stock in the coming months…

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

3 Aussie passive income stocks delivering decades upon decades of dividends

Income-focused investors could benefit from these stocks.

Read more »